ArticleJTO clinical and research reports2024

Analysis of Baseline Molecular Factors Associated With the Risk of Central Nervous System Progression Among Alectinib-Treated Patients With ALK-Positive NSCLC.

Lianxi Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.